GlassScriptPhysician profile
Robert D Laufer
NPI 1205838737
$7,746.88
in general payments reported to CMS, 2019-2025
55 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,267 · 2020: $1,071 · 2021: $1,661 · 2022: $1,628 · 2023: $1,277 · 2024: $484 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,119.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,023.19 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $825.30 | 2019-2025 | Xifaxan |
| Gilead Sciences, INC. | $787.41 | 2019-2022 | |
| Glaxosmithkline, LLC. | $522.39 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $430.96 | 2019-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $328.43 | 2021-2024 | Dupixent |
| Amgen INC. | $244.36 | 2019-2024 | Repatha, Otezla, Prolia |
| Ardelyx, INC. | $216.06 | 2022-2025 | Ibsrela |
| Janssen Biotech, INC. | $201.73 | 2019-2023 | Stelara |
| United Therapeutics Corporation | $199.06 | 2021-2024 | Tyvaso |
| Grifols USA, LLC | $175.94 | 2019-2023 | Prolastin-C Liquid |
| Ironwood Pharmaceuticals, INC | $166.99 | 2019-2023 | Linzess |
| Lilly USA, LLC | $155.96 | 2019-2025 | Omvoh, Zepbound |
| Actelion Pharmaceuticals US, INC. | $141.77 | 2021-2023 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $140.59 | 2019-2024 | Dificid, Zerbaxa, Recarbrio |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $138.62 | 2022-2023 | Proclaim, Freestyle Libre 2, Octrode |
| Novo Nordisk INC | $136.86 | 2019-2024 | Ozempic, Rybelsus |
| Celgene Corporation | $121.57 | 2021-2024 | Zeposia |
| Nestle Healthcare Nutrition INC. | $119.30 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $116.97 | 2019-2022 | |
| Advanced Respiratory, INC | $106.52 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $96.94 | 2019-2023 | |
| Daiichi Sankyo INC. | $96.53 | 2019-2022 | |
| Redhill Biopharma INC. | $82.05 | 2020-2022 | |
| Pulmonx Corporation | $78.88 | 2022-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Covis Pharma Gmbh | $75.20 | 2021-2023 | |
| Genzyme Corporation | $74.25 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $70.67 | 2019-2022 | |
| Insmed, INC. | $68.94 | 2022-2025 | Arikayce |
| Mylan Specialty L.P. | $67.43 | 2019-2024 | Yupelri |
| Dexcom, INC. | $55.16 | 2023-2024 | Dexcom G6 Transmitter |
| Mallinckrodt Hospital Products INC. | $55.08 | 2022 | |
| Boston Scientific Corporation | $54.41 | 2020-2021 | |
| Baxter Healthcare | $54.23 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Mylan Institutional INC. | $50.35 | 2023 | Hulio |
| Takeda Pharmaceuticals U.S.A., INC. | $43.44 | 2020-2022 | |
| Sanofi Pasteur INC. | $41.48 | 2019-2023 | |
| Pfizer INC. | $40.54 | 2019-2022 | |
| Topcon Healthcare Solutions, INC. | $39.38 | 2019 | |
| Viatris Specialty LLC | $37.02 | 2025 | Yupelri |
| Impulse Dynamics (USA) INC. | $29.78 | 2022-2023 | Optimizer |
| Sunovion Pharmaceuticals INC. | $25.30 | 2019 | |
| Biocon Biologics INC | $22.98 | 2024 | Hulio |
| Phadia US INC. | $19.13 | 2023 | Immunocap |
| Allergan, INC. | $18.87 | 2020 | |
| Braintree Laboratories, INC. | $17.88 | 2021 | |
| Intercept Pharmaceuticals, INC. | $16.89 | 2022 | |
| Exact Sciences Corporation | $16.02 | 2023 | Cologuard Collection Kit |
| Alfasigma USA, INC. | $15.69 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $14.67 | 2021 | |
| Oxford Immunotec USA INC | $14.45 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.12 | 2021 | |
| Shire North American Group INC | $14.11 | 2019 | |
| Ethicon US, LLC | $12.73 | 2020 | |
| Covidien LP | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Laufer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.